A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

Clinical trial NCT04669171 · RECRUITING

Trial details

NCT number: NCT04669171
Sponsor: Enterome
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Follicular Lymphoma Marginal Zone Lymphoma

Start date: 2021-07-05
Primary completion: 2029-05-30
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.